Dhathri joined BPRU in July 2022 after graduating from the University at Buffalo with a B.S. in Public Health. Her undergraduate research areas included nicotine effects in humans and developing a precision dosing model for vancomycin. Her current research primarily evaluates the efficacy of an FDA-approved anxiety medication in alleviating opioid withdrawal symptoms and anxiety. As well as examining the pharmacokinetics and pharmacodynamics of oral CBG. In her free time, she enjoys traveling, and rock climbing.